<p>CAR T-cell therapy is a newer form of immunotherapy that can treat some types of blood cancers, such as lymphoma, multiple myeloma, and leukemia.  Patients can be treated with this therapy as an inpatient or outpatient, depending on their case and specific needs.   “Historically, we were giving these therapies in the hospital, but what we’ve learned over the last few years is that outpatient therapy is very safe ... <a class="read-more" href="https://blog.dana-farber.org/insight/2026/03/car-t-cell-therapy-inpatient-vs-outpatient/" title="What’s…
What’s the Difference Between Outpatient and Inpatient CAR T-Cell Therapy?
Dana-Farber Cancer Institute | | Maddi Langweil
Topics: blood-cancer, immunotherapy